K. Bertelsen

发表

Vascular Effects of RWJ‐676070, a Selective Combined V1a/V2 Vasopressin Receptor Antagonist

M. Burnier, M. Maillard, B. Vogt, 2009, Clinical pharmacology and therapeutics.

Pharmacokinetic interaction between etravirine or rilpivirine and telaprevir in healthy volunteers: A randomized, two‐way crossover trial

H. Crauwels, T. Kakuda, R. Hoetelmans, 2014, Journal of clinical pharmacology.

Translational evaluation of JNJ-18038683, a 5-HT7 receptor antagonist, on REM sleep and in major depressive disorder

P. Bonaventure, C. Dvorak, T. Lovenberg, 2012 .

REM sleep and in major depressive disorder

P. Bonaventure, W. Chai, C. Dvorak, 2012 .

A Brief Survey of First‐in‐Human Studies

K. Bertelsen, D. Wexler, 2011, Journal of clinical pharmacology.

Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: comparison with fluoxetine and quinidine.

D. Greenblatt, R. Obach, K. Venkatakrishnan, 2003, Drug metabolism and disposition: the biological fate of chemicals.

Telaprevir twice daily is noninferior to telaprevir every 8 hours for patients with chronic hepatitis C.

M. Buti, S. Zeuzem, M. Rizzetto, 2014, Gastroenterology.

Apparent active transport of MDMA is not mediated by P‐glycoprotein: a comparison with MDCK and Caco‐2 monolayers

D. Greenblatt, L. V. von Moltke, K. Bertelsen, 2006, Biopharmaceutics & drug disposition.

Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study

S. Vermeire, B. Sands, W. Sandborn, 2018, Journal of Crohn's & colitis.

Overall safety of relamorelin in adults with diabetic gastroparesis: Analysis of phase 2a and 2b trial data

M. Camilleri, A. Lembo, R. McCallum, 2020, Alimentary pharmacology & therapeutics.

Simultaneous determination of tolbutamide, omeprazole, midazolam and dextromethorphan in human plasma by LC-MS/MS--a high throughput approach to evaluate drug-drug interactions.

Wei Zhang, Naidong Weng, F. Han, 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Translational Evaluation of JNJ-18038683, a 5-Hydroxytryptamine Type 7 Receptor Antagonist, on Rapid Eye Movement Sleep and in Major Depressive Disorder

P. Bonaventure, C. Dvorak, T. Lovenberg, 2012, Journal of Pharmacology and Experimental Therapeutics.

Effects of JNJ-40929837, a leukotriene A4 hydrolase inhibitor, in a bronchial allergen challenge model of asthma.

R. Thurmond, A. Fourie, J. Lambert, 2014, Pulmonary pharmacology & therapeutics.

A highly sensitive and selective method for the determination of leukotriene B4 (LTB4) in ex vivo stimulated human plasma by ultra fast liquid chromatography-tandem mass spectrometry.

A. Fourie, Naidong Weng, J. D. de Jong, 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.